|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Science, Nature & Technology

There Is a Link Between AstraZeneca, Blood Clots: EMA Official

ROME -- There is a link between the AstraZeneca Covid-19 vaccine and rare cares of blood clots developing in people who have received the inoculation, the head of vaccine strategy at the European Medicines Agency (EMA) said Tuesday.

Marco Cavaleri’s comments to the Il Messaggero newspaper in Italy comes after the EMA, the World Health Organization and AstraZeneca last month said that the vaccine was safe to use and that its positive impacts outweighed any risks of potential side effects, such as thrombosis.

“In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction,” Cavaleri said.

"We are trying to get an accurate picture of what is happening, to define in detail this syndrome due to the vaccine," he added.

A source from the EMA told Efe later on Tuesday the regulator has yet to reach a firm conclusion on whether there is a connection between the vaccine and the blood clots, insisting their investigation was “still underway.”

The Pharmacovigilance Risk Assessment Committee (PRAC), an EMA committee responsible for assessing the safety of human medicines, has meetings scheduled from Tuesday to Friday to conclude its investigations into the possible link between the vaccine and thrombosis.

Cavaleri said that blood clots had developed in the brain in some cases after getting the AstraZeneca jab “among young people more than what we would expect.”

Several EU countries have suspended the use of AstraZeneca's coronavirus jab, while Netherlands and Germany have decided to limit its use to people of certain ages.

"They can do it, they can impose a precautionary principle taking into account that they have other vaccines available," he underlined.
 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2021 © All rights reserved